ArticleInternational journal of molecular sciences2023

Fisetin, an Anti-Inflammatory Agent, Overcomes Radioresistance by Activating the PERK-ATF4-CHOP Axis in Liver Cancer.

Tae Woo KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.